Imagion Biosystems Ltd (IBXXF)

[ssc]

hncher, I see the ibx 2017 annual report is out. Are you still standing by your statement that "they shouldn't run out of cash!"? Price seems to be saying otherwise, as well as the fact ibx has less than $7 million in cash left, burning $7 million/year and that burn rate doesn't even include what they'll have to pay outside companies for major agreements. From the annual report:

These agreements would include, manufacturing for our formulated nanoparticle, design and prototype production of our instrument, clinical consultants among other things.

Seems like they will be running out of cash in a big way imo.